NAC to Prevent Cisplatin-induced Hearing Loss
Conditions: Neuroectodermal Tumors, Primitive; Liver Neoplasms; Neoplasms, Germ Cell and Embryonal; Osteosarcoma; Other Childhood Cancers Using Cisplatin-based RegimensIntervention: Drug: N-AcetylcysteineSponsor: Children's Hospital Los AngelesNot yet recruiting - verified January 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bone Cancers | Cancer | Cancer & Oncology | Children | Embryonal Carcinoma | Neurology | Osteosarcoma | Research